Development
of Controlled Release Floating Beads of Ibuprofen using Ionotropic
Gelation Technique
P.S. Salve*
Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University Campus, Mahatma Fuley Shaikshanik Parisar, Amravati Road, Nagpur – 440 033 (MS)
ABSTRACT:
The
floating beads of ibuprofen were developed to provide controlled release in stomach. The beads were developed by ionotropic
gelation of low methoxy
pectin with calcium ions. The drug loading was kept at 25, 50 and 75 %w/w of
low methoxy pectin (LMP). Sesame
oil was used to provide floating characteristic in 10, 20 and 30 %w/w of (LMP).
The beads were cross-linked with 2, 4 and 10 %w/v CaCl2 solution and
further coated with 1 %w/v solution of deacetylated
chitosan in 3 %w/v acetic acid. The interaction of low methoxy
pectin with calcium ions and deacetylated chitosan
was studied by differential scanning calorimetry,
x-ray diffraction spectroscopy and FT-IR spectroscopy. The in-vitro buoyancy studies were carried in pH 1.2 buffer.
The polymeric beads containing 20 and 30 %w/v oil showed excellent floating
while beads containing 10 %w/v oil were found to be non-floating. The
dissolution studies were carried in pH 1.2 buffer, pH
1.2 buffer containing 1% SLS and pH 6.8 phosphate buffer. A significantly low
amount of drug release was observed in pH 1.2 buffer
due to limited solubility of obuprofen in acidic
media and faster drug release was observed in pH 6.8 phosphate buffer. A faster
drug release was observed in pH 1.2 buffer containing sodium lauryl sulphate.
KEYWORDS: Ionotropic gelation, floating, controlled release, polymeric beads.
INTRODUCTION:
Multiple
unit floating drug delivery system is of advantage as
compared to single unit floating drug delivery system (Iannuccelli
et al., 1998). The gastric emptying of multiple unit floating drug delivery
systems would occur in consistent manner with small individual variations. On
each subsequent gastric emptying, sunken units will spread out more uniformly
over large area of absorption sites, increasing opportunity for drug release
profile and absorption in more predictable way (Acikgoz
et al., 1995). Moreover, since each dose consists of many subunits, the risk of
dose dumping is reduced (Iannuccelli et al., 1998).
The concept of floating multiple unit drug delivery systems can also be
utilized to minimize the irritant effect of weakly acidic drugs on the stomach
by avoiding direct contact with the mucosa and providing a mean of getting low
dosage for prolonged periods (Thanoo et al., 1993).
Natural
biodegradable polysaccharides like pectin, sodium alginate, chitosan, carrageenans, and gellan gum have
been used in controlled drug delivery1–5. Multiparticulate
systems obtained by ionotropic cross-linking of these
polymers have been used to develop floating drug delivery. The approaches to
induce buoyancy in cross-linked beads includes freeze-drying, entrapment of gas
or gas forming agents, use of volatile oils or fixed oils6–8.
These approaches are
complicated, as they require specific equipment and handling techniques with
limited acceptance.
The
polysaccharide pectin is a polymer of α-D-galacturonic
acid with 1→4 linkages. This chain is regularly interrupted by some rhamnogalacturonan segments that combine galacturonic acid residues and α-L–rhamnopyranose
by a 1→2 linkage. The galacturonic acid of the
backbone is partially methyl-esterified. Low-methoxy pectin with degree of esterification
less than 50% can form rigid gels by the action of calcium ions or multivalent cations, which cross-link the galacturonic
acid chains. Calcium pectinate hydrogels
are stable in low pH solution and are being investigated as a carrier material
for different controlled release systems. The use of vegetable oil in calcium pectinate beads will provide buoyancy to the beads as well
as will control the drug release from the beads. The oil containing beads have
limitations of coalescence of oil droplets yield yielding beads of wider
particle size distribution, volatilization or leaching of oil9.
Ibuprofen
is a well known non-steroidal anti-inflammatory agent effective in rheumatic
diseases. It is a weak acid having pKa 4.4 and 5.2.
It is having irritation potential in stomach due to charged carboxylic acid. It
is well absorbed from upper small intestine. Therefore, it was envisaged to
develop floating beads of ibuprofen.
MATERIALS AND
METHODS:
Materials
Chitosan (degree of deacetylation
= 87%) and low methoxy pectin were obtained from TIC
Gum Inc. USA, sesame oil was obtained from Samar Chemicals, Nagpur, Ibufrofen was gratis sample from Zim
Laboratories, Nagpur, sodium hydroxide, potassium dihydrogen
orthophosphate, sodium lauryl sulphate
were obtained from Loba Chemie
Pvt. Ltd., Conc. Hydrochloric acid was obtained from Rankem
Ltd. Calcium chloride, sodium chloride were pbtained
from S.D. Fine Chemicals. Ltd. The other reagents and
chemicals were of analytical grade.
Methods
Preparation
of floating polymeric beads
The
formulation of floating beads is shown in table 1. A 5 %w/v solution of low methoxy pectin solution was prepared in distilled water. To
it, ibuprofen was added in dosing levels of 25, 50 and 75 %w/v of pectin
weight. The dispersion was stirred using mechanical stirrer. Sesame oil was added
in 10, 20 and 30 %w/v of volume dispersion. The solution was stirred to make a
homogeneous dispersion of oil, drug and pectin.
A 5
%v/v acetic acid solution was prepared in distilled water and to it gradually
chitosan (87% degree of deacetylation) was added to
make 1 %w/v solution. The solution was kept overnight. In distilled water
calcium chloride was dissolved and it was added to solution of chitosan to get
2, 4, and 10 %w/v solution of CaCl2. Hence the final individual
solutions were 1% w/v chitosan containing 2, 4 and 10 %w/v of calcium chloride.
The
dispersion of low methoxy pectin, drug and oil was
added under stirring through 22 Gauge needle into 1 %w/v chitosan solution in
acetic acid containing 2, 4 and 6% CaCl2 solution separately. The
curing time for the reaction between pectin, chitosan and CaCl2 was
kept at 30 minutes. The beads were separated by filtration and dried at 37oC
for 24 hours.
Table 1 Formulation batches floating polymeric beads
|
Formulation batch
code |
Low methoxy pectin dispersion (%w/v) |
Drug loading (%) |
Sesame oil (%) |
CaCl2 solution (%w/v) |
|
F1 |
5 |
25 |
10 |
2 |
|
F2 |
5 |
25 |
20 |
2 |
|
F3 |
5 |
25 |
30 |
2 |
|
F4 |
5 |
50 |
10 |
2 |
|
F5 |
5 |
50 |
20 |
2 |
|
F6 |
5 |
50 |
30 |
2 |
|
F7 |
5 |
75 |
10 |
2 |
|
F8 |
5 |
75 |
20 |
2 |
|
F9 |
5 |
75 |
30 |
2 |
|
F10 |
5 |
25 |
10 |
4 |
|
F11 |
5 |
25 |
20 |
4 |
|
F12 |
5 |
25 |
30 |
4 |
|
F13 |
5 |
50 |
10 |
4 |
|
F14 |
5 |
50 |
20 |
4 |
|
F15 |
5 |
50 |
30 |
4 |
|
F16 |
5 |
75 |
10 |
4 |
|
F17 |
5 |
75 |
20 |
4 |
|
F18 |
5 |
75 |
30 |
4 |
|
F19 |
5 |
25 |
10 |
10 |
|
F20 |
5 |
25 |
20 |
10 |
|
F21 |
5 |
25 |
30 |
10 |
|
F22 |
5 |
50 |
10 |
10 |
|
F23 |
5 |
50 |
20 |
10 |
|
F24 |
5 |
50 |
30 |
10 |
|
F25 |
5 |
75 |
10 |
10 |
|
F26 |
5 |
75 |
20 |
10 |
|
F27 |
5 |
75 |
30 |
10 |
Characterization
Size of beads
In
the surface characteristic studies, a chitosan coating over the pectin beads
was observed by using MOTIC Software.
Drug content
For
determination of drug content, the polymeric beads were sonicated
in pH 6.8 phosphate buffer and washed till the total drug removed from the
beads. The absorbance was recorded at 221 nm.
In
vitro buoyancy test
The floating characteristic of polymeric
beads was studied in pH 1.2 buffer containing 0.02% tween
80.
Interaction studies of low methoxy pectin with calcium ions and deacetylated
chitosan
Differential Scanning Calorimetry
(DSC)
The
interaction of low methoxy pectin with calcium ions
and chitosan was studied by DSC. The DSC thermogram
of calcium pectinate beads containing ibuprofen and
sesame oil was recorded. Also, the DSC thermogram of calcium pectinate
beads containing ibuprofen, sesame oil and coated with deacetylated
chitosan was recorded at a heating rate of 5oC/minute.
X-ray diffraction spectroscopy
The
interaction of low methoxy pectin with chitosan and
calcium ions was studied by x-ray diffraction spectroscopy. The x-ray
diffraction pattern of calcium pectinate beads
containing ibuprofen and sesame oil was recorded. Also, the x-ray diffraction pattern of
calcium pectinate beads containing ibuprofen, sesame
oil and coated with chitosan was recorded.
FT-IR spectroscopy
The
FT-IR spectrum of calcium pectinate beads containing
ibuprofen and sesame oil was recorded.
Also, the FT-IR spectrum of calcium pectinate
beads containing ibuprofen, sesame oil and coated with chitosan was recorded in
the stretching frequency range 400 to 4000 cm-1. For
the preparation of samples by KBr press pellet
technique, a 3:1 ratio of KBr: sample was used.
In vitro dissolution studies
The in
vitro dissolution was carried out in pH 1.2 buffer, pH 6.8 phosphate buffer
and pH 1.2 buffer containing 1 %w/v SLS using USP type II dissolution test
apparatus at 37±0.5oC at 75 rpm. The polymeric beads equivalent to
200 mg of ibuprofen were used for dissolution studies. The drug content was
measured at 221 nm.
RESULTS AND DISCUSSION:
Determination
of drug content
The maximum drug loading was found to be 75% of low methoxy pectin weight used in the formulation of beads.
Determination
of size of beads
The
diameter of beads studied using MOTIC Software was found to be 100µm±5 µm. In
the surface characteristic studies, a chitosan coating over the pectin beads
was observed.
In
vitro buoyancy studies
The polymeric beads containing 10%
sesame oil were found to be non-floating and beads containing 20 and 30% sesame
oil were found to show excellent floating characteristic in pH 1.2 buffer.
Interaction
study of low methoxy pectin with calcium ions and
chitosan
Differential Scanning Calorimetry
(DSC)
Figure 1 DSC thermogram
of ibuprofen
Figure 2 DSC thermogram of deacetylated
chitosan
Figure 3 DSC thermogram of low methoxy pectin
Figure 4 DSC thermogram
of ibuprofen loaded polymeric beads of low methoxy
pectin and sesame oil cross-linked with calcium chloride
Figure 5 DSC thermogram
of ibuprofen loaded polymeric beads of low methoxy
pectin and sesame oil cross-linked with calcium chloride and coated with deacetylated chitosan
The thermal transitions and
enthalpy values of ibuprofen, deacetylated chitosan,
low methoxy pectin, and ibuprofen loaded polymeric
beads with and without coating of chitosan are shown in table 2.
Table
2 Thermal transitions and enthalpy values of ibuprofen, deacetylated
chitosan, low methoxy pectin, and ibuprofen loaded
polymeric beads with and without coating of chitosan
|
Sample |
DSC thermal transition (0C) |
Enthalpy (J/g) |
|
Ibuprofen |
76.89 239.71 286.56 |
(-)337.33 355.53 501.05 |
|
Deacetylated chitosan |
60.31 289.80 |
(-)87.04 826.98 |
|
Low
methoxy pectin |
78.89 150.29 200.79 309.68 |
(-)
479.38 (-)
115.03 (-)
483.45 1605.25 |
|
Polymeric
beads of low methoxy pectin and sesame oil cross-linked with calcium chloride |
90.78 204.10 313.30 369.22 |
9999.0 9999.0 9999.0 9999.0 |
|
DSC
thermogram of polymeric beads of low methoxy pectin and sesame oil cross-linked with calcium
chloride and coated with deacetylated chitosan |
Glass
transition Onset
42.73 Midpoint
61.60 194.99 |
---- ---- (-)
30.80 |
As shown in figure 1, a sharp melting
peak at 76.89ºC with an enthalpy value of (-) 337.33 J/g was observed in the
DSC thermogram of ibuprofen indicating that heat is
absorbed by system for melting process. The other peaks at 239.71 and 286.56ºC
are exotheric peaks with enthalpy values of 355.53
and 501.05 J/g respectively indicating heat is liberated by the system.
The DSC thermogram
of deacetylated chitosan is shown in figure 2. It has
shown a melting peak at 60.31oC with an enthalpy value of (-) 87.04
J/g. The other peak observed is the exothermic transition at 289.80 with an
enthalpy value 826.38 J/g.
The DSC thermogram
of low methoxy pectin is shown in figure 3. It has
shown a melting peak at 78.89, 204.10, and 313.30oC with enthalpy
values of (-) 479.38, (-) 115.03 and (-) 483.45 respectively. The other peak
observed is the exothermic transition at 309.68ºC with an enthalpy value
1605.25 J/g.
The DSC thermogram
of polymeric beads of ibuprofen containing low methoxy
pectin and sesame oil cross-linked with calcium chloride is shown in figure 4.
It has shown the endothermic transitions at 90.78, 204.10, 313.30, with
enthalpy values of 9999 J/g for each thermal transition and an exothermic
transition at 369.22ºC with enthalpy value of 9999 J/g.
The DSC thermogram
of polymeric beads of ibuprofen containing low methoxy
pectin and sesame oil cross-linked with calcium chloride and coated with deacetylated chitosan is shown in figure 5. It has shown
glass transition as the thermal transition with an onset at 42.73ºC and a
midpoint 61.60ºC. An endothermic transition at 194.99ºC with an enthalpy value
of (-) 30.80 J/g was observed. It
indicates that a transition of the polymer from one rubbery state to glassy
state has occurred due to complex formation as evidenced by the glass
transition temperature at 42.73oC. The midpoint of glass transition
peak at 61.60ºC is similar to the melting peak of deacetylated
chitosan which was observed at 60.31ºC.
From the above thermal transitions, it
can be concluded that the endothermic peak of low methoxy
pectin which was observed at 150.29ºC with an enthalpy value of (-) 115.03 J/g
has been disappeared from the thermogram of polymeric
beads of low methoxy pectin and sesame oil
cross-linked with calcium chloride. Also the endothermic peak of low methoxy peak which was observed at 78.89ºC was found to be
shifted to 90.78ºC indicating more energy was required for the melting due to
cross-linking.
FT-IR Spectroscopy
Figure 6 FT-IR spectrum of ibuprofen
Figure 7 FT-IR spectrum of low methoxy pectin
Figure 8 FT-IR spectrum of deacetylated chitosan
Figure 9 FT-IR spectrum of polymeric beads of low methoxy
pectin and sesame oil cross-linked with calcium chloride
Figure 10 FT-IR spectrum
of polymeric beads of low methoxy pectin and sesame
oil cross-linked with calcium chloride and coated with deacetylated
chitosan
The
FT-IR spectrum of deacetylated chitosan has shown the
stretching frequencies at 3500 cm-1 due to presence of primary amine
functional groups. The stretching frequency representing primary amine
functional group was absent in the FT-IR spectrum of polymeric beads of low methoxy pectin cross-linked with calcium ions and coated
with chitosan. The FT-IR spectras of pectin beads
cross-linked with calcium ions and pectin beads cross-linked with calcium ions
and coated with chitosan has shown the stretching frequency at 3009 cm-1
due to = C-H stretching (Aliphatic) functional group. Hence the structural
change to alkenes might have occured due to
cross-linking of pectin with calcium ions. The stretching frequencies at 1545,
1535 cm-1 were due to secondary –CONH- stretching or RCO2
functional groups. The secondary –CONH- stretching might be due to interaction
of amine group of chitosan with the carboxylic acid group of the low methoxy pectin. The stretching frequencies observed due to
presence of functional groups RCOOH, ester C = O stretching, aldehyde C = O stretching were observed in low methoxy pectin but were absent in polymeric beads of low methoxy pectin containing sesame oil and cross-linked with
calcium ions indicates that the carboxylic acid functionality either RCOOH,
ester C = O, aldehyde C = O have been utilized for
the reaction between negatively charged pectin and positively charged chitosan.
X-ray
diffraction spectroscopy
Figure 11 X-ray diffraction pattern of
ibuprofen
Figure 12 X-ray diffraction pattern of
low methoxy pectin
Figure 13 X-ray
diffraction pattern of deacetylated chitosan
Figure 14 X-ray diffraction patterns of polymeric beads of
ibuprofen containing low methoxy pectin and sesame
oil cross linked with calcium ions
Figure 15 X-ray diffraction pattern of
polymeric beads of ibuprofen containing low methoxy
pectin, sesame oil cross-linked with calcium ions and coated with deacetylated chitosan
The
x-ray diffraction pattern of ibuprofen and low methoxy
pectin is shown in figure 11 and 12 respectively. It showed the sharp peak
since ibuprofen and low methoxy pectin are present in
crystalline state. Whereas, as shown in figure 13, the deacetylated chitosan was present in the amorphous state as
evidenced from the diffused pattern. The x-ray diffraction pattern of
polymeric beads of ibuprofen containing low methoxy
pectin, sesame oil cross-linked with calcium ions is shown in figure 14. It
shows the absence of sharp crystalline peaks of either ibuprofen or low methoxy pectin. The x-ray diffraction pattern of polymeric
beads of ibuprofen containing low methoxy pectin,
sesame oil, cross-linked with calcium ions and coated with deacetylated
chitosan are shown in figure 15 which shows the absence of sharp crystalline
peaks of either ibuprofen or low methoxy pectin. It
indicates the complex formation between low methoxy
pectin, calcium chloride and deacetylated chitosan
leading to the development of polymeric beads.
Dissolution studies of ibuprofen polymeric beads in pH
1.2 buffer
Figure 16 Release
profiles of ibuprofen polymeric beads loaded with 25 % drug, 20 and 30% sesame
oil and cross-linked with 2, 4 and 10% CaCl2 in pH 1.2 buffer
In
the in vitro buoyancy studies in pH 1.2 buffer, the
polymeric beads containing 10% sesame oil were found to be non-floating. Hence
the dissolution studies were carried out using the formulation batches with 20
and 30% sesame oil.
As
shown in figure 16, the formulation batches with a drug loading of 25%, and
containing 20 and 30% sesame oil and cross-linked with 2, 4 and 10 %w/v CalCl2,
6 to 8 % drug release was observed in 1 hour and 12 to 14% drug release was
observed after 10 hours of dissolution studies. The formulation batches have
shown Peppas model as the best fit model of drug
release.
Figure 17 Release profiles of ibuprofen
polymeric beads loaded with 50 % drug, 20 and 30% sesame oil and cross-linked
with 2, 4 and 10% CaCl2 in pH 1.2 buffer
As
shown in figure 17, the formulation batches with a drug loading of 50%, with 20
and 30% sesame oil and cross-linked with 2, 4 and 10 %w/v CalCl2 has
shown a release of 6 to 7 % drug release in 1 hour and 14 to 18% drug release
was observed after 10 hours of dissolution studies. The formulation batch F5
and F23 have shown matrix as the best fit model, whereas, F6,
F14, F15, F24 has shown Peppas
model as the best fit model of drug release.
Figure 18 Release profiles
of ibuprofen polymeric beads loaded with 75 % drug, 20 and 30% sesame oil and
cross-linked with 2, 4 and 10% CaCl2 in pH 1.2 buffer
As
shown in figure 18, the formulation batches with a drug loading of 75%, with 20
and 30% sesame oil and cross-linked with 2, 4 and 10 %w/v CalCl2 has
shown a 4 to 5 % drug release in first hour and 12 to 17% drug release was
observed after 10 hours of dissolution studies. The formulation batch F8,
F9, F17, F18, F27 have shown matrix
as the best fit model, whereas, formulation batch F26 has shown Peppas model as the best fit model of drug release.
Dissolution
studies of ibuprofen polymeric beads in pH 1.2 buffer containing 1% SLS
The
in vitro dissolution of ibuprofen polymeric beads in pH 1.2 buffer
has shown 10-19% drug release after 10 hours. It was due to limited solubility
of ibuprofen in pH 1.2 buffer. Hence, the drug release
studies were carried in pH 1.2 buffer containing 1 %w/v sodium lauryl sulphate. In pH 1.2 buffer
containing 0.5 %w/v sodium lauryl sulphate,
ibuprofen was found to be partly soluble; hence the proportion of SLS was
increased to 1 %w/v. Also, the solubility of ibuprofen in 3 %w/v tween 80 was studied but it was not possible to measure the
drug concentration in pH 1.2 buffer containing
3 %w/v tween 80 because the absorbance values
at 221 nm were found to be fluctuating and not stable due to lower wavelength
221 nm.
Figure 19 Release profiles of ibuprofen polymeric beads loaded
with 25 % drug, 20 and 30% sesame oil and cross-linked with 2, 4 and 10% CaCl2 in pH 1.2
buffer containing 1% SLS
As shown in figure 19, the formulation
batches with a drug loading of 25%, with 20 and 30% sesame oil and cross-linked
with 2, 4 and 10 %w/v CalCl2 has shown a release of 22 to 36 % drug
release in 1 hour. The formulation batches cross-linked with 2% CaCl2 and
20% oil, a drug release of 62% was observed. Whereas, the formulation batch
containing 30% oil and cross-linked with 2% CaCl2 has shown a drug
release of 69% after 10 hours. The drug release was increased when the CaCl2
concentration was increased from 2 to 4% and in the formulation batches with 20
and 30% oil, 93 and 100% drug release was observed after 10 hours. It indicates
that the higher calcium ion concentration has competed with chitosan and hence
faster drug release was observed. Similarly, the formulation batches containing
30 and 30% oil and cross-linked with 10% CaCl2 has shown a drug
release of 85 and 100% respectively after 10 hours. The formulation batches F2
and F3 has shown Peppas model as best fit
model of drug release, whereas, the formulation batches F11, F12,
F20, and F21 has shown matrix drug release kinetic model.
Figure 20 Release profiles of ibuprofen polymeric beads loaded
with 50 % drug, 20 and 30% sesame oil and cross-linked with 2, 4 and 10% CaCl2 in pH 1.2
buffer containing 1% SLS
As
shown in figure 20, the formulation batches with a drug loading of 50%, with 20
and 30% sesame oil and cross-linked with 2, 4 and 10 %w/v CalCl2 has
shown a 19 to 27 % drug release in 1 hour. The formulation batches cross-linked
with 2% CaCl2 and 20% oil, a drug release of 61% was observed after
10 hours. Whereas, the formulation batch containing 30% oil and cross-linked
with 2% CaCl2 has shown a drug release of 59% after 10 hours. The
drug release was increased when the CaCl2 concentration was
increased from 2 to 4% and in the formulation batches with 20 and 30% oil, 84
and 95% drug release was observed after 10 hours. It indicates that the higher
calcium ion concentration has competed with chitosan and hence faster drug
release was observed. Similarly, the formulation batches containing 20 and 30%
oil and cross-linked with 10% CaCl2 has shown a drug release of 80
and 93% respectively. The formulation batches F5, F6, F14
has shown Peppas model as best fit model of drug
release, whereas, the formulation batches F15, F23, F24
has shown matrix drug release kinetic model.
Figure 21 Release profiles of ibuprofen polymeric beads loaded
with 75 % drug, 20 and 30% sesame oil and cross-linked with 2, 4 and 10% CaCl2 in pH 1.2 buffer
containing 1% SLS
As
shown in figure 21, the formulation batches with a drug loading of 75%, with 20
and 30% sesame oil and cross-linked with 2, 4 and 10 % CalCl2 has
shown a release of 18 to 31 % drug release in 1 hour. The formulation batches
cross-linked with 2% CaCl2 with 20 and 30% sesame oil, a drug
release of 53 and 56% respectively was observed after 10 hours. In the
formulation batches with 20 and 30% oil, and cross-linked with 4% CaCl2,
70 and 88% drug release respectively was observed after 10 hours. It indicates
that the higher calcium ion concentration has competed with chitosan for
forming a complex with chitosan and hence faster drug release was observed.
Similarly, the formulation batches containing 20 and 30% oil and cross-linked
with 10% CaCl2 has shown a drug release of 65 and 64% respectively.
The formulation batches F8, F9, F18 has shown Peppas model of drug release as best fit model, whereas,
the formulation batches F17, F26, and F27 has shown matrix drug release
kinetic model.
Dissolution studies of ibuprofen
polymeric beads in pH 6.8 phosphate buffer
Figure 22 Release profiles of ibuprofen polymeric beads loaded with 25
% drug, 20 and 30% sesame oil and cross-linked with 2, 4 and 10% CaCl2
in pH 6.8 phosphate buffer
The
drug release profiles of ibuprofen polymeric beads with 25% drug loading in pH
6.8 phosphate buffer are shown in figure 22. The
formulation batches containing 20 and 30% sesame oil and cross-linked with 2%
CaCl2 has shown complete drug release after 3 hours of dissolution
studies. Whereas, when the CaCl2 concentration was increased to 4%,
the complete drug release was observed after 4 hours. The drug release was sustained
when the CaCl2 concentration was increased to 10%. The complete drug
release was observed after 6 and 8 hours in case of the formulation containing
20 and 30% respectively oil and cross-linked with 10% CaCl2.
Figure 23 Release profiles of ibuprofen
polymeric beads loaded with 50 % drug, 20 and 30% sesame oil and cross-linked
with 2, 4 and 10% CaCl2 in pH 6.8 phosphate buffer
The
release profiles of ibuprofen polymeric beads with 50% drug loading, 20 and 30%
sesame oil and cross-linked with 2, 4 and 10% CaCl2 are shown in
figure 23. The formulation batch containing 20 and 30% sesame oil and 2% CaCl2
has shown a release of 19 and 28 % respectively in first hour and the complete
release was observed after 6 hours of dissolution
studies. The formulation batches containing 20 and 30% sesame oil and
cross-linked with 4% CaCl2 has shown a release of 8 and 13% after 1
hour and the complete release was observed after 8 hours. The drug release was
further sustained in case of the formulation containing 20 and 30% sesame oil
and cross-linked with 10% CaCl2 and 14 and 12% drug release was
observed after 1 hour of dissolution studies. After 8 hours, 85 and 58% drug
release was observed in case of formulation containing 20 and 30% sesame oil
respectively. The proportion of oil when increased from 20 to 30% the drug
release was retarded from 85 to 58%. It is due to partitioning of drug into the
oil phase and at the same time increase in the rigidity of polymeric network.
Figure 24 Release profiles of ibuprofen
polymeric beads loaded with 75% drug, 20 and 30% sesame oil and cross-linked
with 2, 4 and 10% CaCl2 in pH 6.8phosphate buffer
The
release profiles of ibuprofen polymeric beads with 75% drug loading, 20 and 30%
sesame oil and cross-linked with 2, 4 and 10% CaCl2 are shown in
figure 24 The formulation batch containing 20 and 30% sesame oil and 2% CaCl2
has shown a release of 29.57 and 39.39 % respectively in first hour and
the complete release was observed after 6 hours of dissolution studies. The
formulation batches containing 20 and 30% sesame oil and cross-linked with 4%
CaCl2 has shown a release of 9.07 and 13.98% after 1 hour and 92.38
and 98.65% drug release was observed after 8 hours. The drug release was
further sustained in case of the formulation containing 20 and 30% sesame oil
and cross-linked with 10% CaCl2 and 1.90 and 4.70% drug release was
observed after 1 hour of dissolution studies. After 8 hours, 36.28 and 69.68%
drug release was observed in case of formulation containing 20 and 30% sesame
oil respectively. The drug release was retarded up to 36.28% due to
partitioning of drug into the oil phase and at the same time increase in the
rigidity of polymeric network by higher concentration of CaCl2 used
for the cross-linking purpose.
CONCLUSION:
From
above dissolution studies of ibuprofen polymeric beads has show low amount of
drug release in pH 1.2 buffer due to limited
solubility of drug in acidic media. The dissolution studies in pH 1.2 buffer
containing 1% w/v sodium lauryl sulphate
has shown increase in drug release due to increased solubility of ibuprofen.
Similarly faster drug release was observed in pH 6.8 phophate
buffer. Hence, it was concluded that multiple unit floating drug delivery of
ibuprofen was developed to control the drug release in acidic condition of
stomach and hence the drug delivery can be used to avoid the irritant effect of
drug on gastric mucosa.
ACKNOWLEDGEMENT:
The
authors are thankful to TIC Gum Inc.
USA for the gift samples of low methoxy pectin and
chitosan. Also for Zim Laboratories
for providing Ibuprofen.
REFERENCES
1.
Pornsak Sriamornsak, Srisagul Sungthongjeen, Satit Puttipipatkhachorn. Use of
pectin as a carrier for intragastric floating drug
delivery: Carbonate salt contained beads. Carbohydrate Polymers 67 (2007)
436–445.
2.
Shraddha S. Badve, Praveen Sher, Aruna Korde,
Atmaram P. Pawar.
Development of hollow/porous calcium pectinate beads
for floating-pulsatile drug delivery. Eur. J.
Pharm. Biopharm.
65 (2007) 85–93.
3.
Pornsak Sriamornsaka, Nartaya Thirawonga, Satit Puttipipatkhachornb.
Emulsion gel beads of calcium pectinate capable of
floating on the gastric fluid: effect of some additives, hardening agent or
coating on release behavior of metronidazole. Eur. J.
Pharm. Sci. 24 (2005) 363–373.
4.
E. Bulgarelli, F. Forni,
M.T. Bernabei. Effect of matrix composition and
process conditions on casein–gelatin beads floating properties. Int. J. Pharm.
198 (2000) 157–165.
5.
Rania A.H. Ishak, Gehanne A.S. Awad, Nahed D. Mortada, Samia A.K. Nour. Preparation, in
vitro and in vivo evaluation of stomach-specific metronidazole-loaded
alginate beads as local anti-Helicobacter pylori therapy. J. Control. Release
119 (2007) 207–214.
6.
Yong-Dan Tang, Subbu S. Venkatraman,
Freddy Y.C. Boey, Li-Wei Wang. Sustained release of
hydrophobic and hydrophilic drugs from a floating dosage form. Int. J. Pharm.
336 (2007) 159–165.
7.
Srisagul Sungthongjeen, Ornlaksana Paeratakul, Sontaya Limmatvapirat, Satit Puttipipatkhachorn.
Preparation and in vitro evaluation of a multiple-unit floating drug delivery
system based on gas formation technique. Int. J. Pharm. 324 (2006) 136–143.
8.
B.Y. Choi, H.J. Park, S.J. Hwang, J.B. Park.
Preparation of alginate beads for floating drug delivery system: effects of CO2
gas-forming agents. Int. J. Pharm. 239 (2002) 81–91.
9.
V. Iannuccelli, G. Coppi, M. T. Bernabei and R. Cameroni. Air compartment multiple-unit system for prolonged gastric residence.
Part I. Formulation study. J. Control.
Release, Vol. 57, Issue 3 (1999) 215-222
10. Whitehead,
J. T. Fell, J. H. Collett, H. L. Sharma, A. M. Smit. Floating dosage forms: an in vivo study demonstrating prolonged gastric
retention. Int. J. Pharm. Vol. 174, Issues 1-2 (1998) 47-54.
Received on 30.09.2011
Accepted
on 28.10.2011
©
A&V Publication all right reserved
Research Journal of Pharmaceutical
Dosage Forms and Technology.
3(6): Nov.- Dec., 2011, 260-268